CVS Health Appoints Teresa Heitsenrether to Board, Larry Robbins Departs
CVS Health announced that Teresa Heitsenrether will join its Board of Directors, bringing decades of data, analytics, and technology operating experience from JPMorgan Chase & Co. Larry Robbins will depart the board after two years. CEO David Joyner said the changes support CVS’s strategy to become a consumer-focused health technology company, aiming to improve customer outcomes and restore value for lenders and shareholders.